Yes I am
- Lets say they can hang onto 2 million MMX shares.
- Cash plus costs plus some shares flow to funder plus KOh and Evans.
MMX once they get past next case have I believe great upside and I see them plus $5 so I can see upside in these shares.
So this is alone is not a bad asset to tuck away. Sitting on say 2 million MMX shares it is quite easy to see what any increase in MMX will mean to CHM.
CHM funder has now funded and won one of the two cases so will be even more comfortable to continue to fund major case. He must be please with the outcome.
MMX have admitted that they have a legacy from past management so its not a great leap forward to believe there is also a legacy in relation to main case.
CHM has part put themselves in the position which they should have been which is a participent in the upside of the IO assets.
I see more to come but think that they have done well to date.
- Forums
- ASX - By Stock
- CHM
- settlement - koh & evans case
CHM
chimeric therapeutics limited
Add to My Watchlist
12.5%
!
0.5¢

settlement - koh & evans case, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.001(12.5%) |
Mkt cap ! $9.068M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $2.418K | 526.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 11217085 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 15687025 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 11217085 | 0.004 |
40 | 26959271 | 0.003 |
17 | 16400505 | 0.002 |
12 | 54150000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 15687025 | 18 |
0.006 | 11718229 | 12 |
0.007 | 3350000 | 3 |
0.008 | 8685291 | 7 |
0.009 | 1149101 | 3 |
Last trade - 15.52pm 01/07/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online